UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, DC 20549

 


 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (date of earliest event reported): December 28, 2005  

 

 

ANGIODYNAMICS, INC.


(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware


(State or Other Jurisdiction of Incorporation)

 

 

0-50761

 

11-3146460


 


 

(Commission File Number)

         (IRS Employer Identification No.)

 

 

 

603 Queensbury Avenue, Queensbury, New York

 

12804


 


 

(Address of Principal Executive Offices)

(Zip Code)

 

 

 

(518) 798-1215


       (Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

Item 5.02.

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

 

(b) On December 28, 2005, AngioDynamics, Inc. (the “Company”) learned of the death that same day of Howard S. Stern, a director and co-founder of the Company. On January 3, 2006, the Company issued a press release announcing Mr. Stern’s death. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference in its entirety.

 

Item 9.01.

Financial Statements and Exhibits

 

 

(d)

Exhibits

 

 

99.1

Press Release issued by AngioDynamics, Inc. on January 3, 2006.

 

 

 

 

2

 



 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 4, 2006

ANGIODYNAMICS, INC.

(Registrant)

 

 

By:/s/ Joseph G. Gerardi                        

Joseph G. Gerardi

Vice President, Chief Financial Officer

 

 

 

 

 

3

 



 

 

EXHIBIT INDEX

 

Exhibit

Description

 

 

99.1

Press Release issued by AngioDynamics, Inc. on January 3, 2006.

 

 

 

 

 

 

4